PBH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Prestige Consumer Healthcare Inc (PBH) is not a good buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock is currently in a bearish trend, with poor financial performance, negative technical indicators, and lack of positive catalysts. It is better to wait for a more favorable entry point or a clear positive catalyst before considering investment.
The stock is in a bearish trend with MACD negatively expanding (-0.682), RSI at 12.725 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is trading below key support levels, with the next support at 50.245.
Hedge funds are significantly increasing their buying activity, with a 622.44% increase in the last quarter.
Insiders are selling heavily, with a 291.04% increase in selling activity over the last month. Analysts have lowered price targets, and financial performance is declining. The stock lacks recent news or event-driven catalysts.
In Q3 2026, revenue dropped by -2.37% YoY to $283.4M, net income dropped by -23.49% YoY to $46.7M, EPS fell by -20.49% YoY to $0.97, and gross margin slightly declined to 53.7%. Overall, the financial performance shows a negative growth trend.
Analysts have lowered price targets recently. Canaccord reduced the target from $88 to $86 while maintaining a Buy rating, citing supply issues with Clear Eyes. Jefferies reduced the target from $70 to $66 and maintained a Hold rating, citing weak U.S. OTC trends and range-bound stock performance until a catalyst emerges.
